Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Baer

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|July 3, 2003
Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftmentT Hahn, U Bunworasate, M C George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administeredJ C Byrd, R K Dodge, A Carroll, et al.
Leukemia|February 16, 2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720M R Baer, S L George, B L Sanford, et al.
Bone Marrow Transplantation|January 25, 2005
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's diseaseT Hahn, M Benekli, C Wong, et al.
Blood|July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabineR M Stone, D T Berg, S L George, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factorsA Alidina, D Lawrence, L A Ford, et al.
Bone Marrow Transplantation|April 25, 2001
Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparinM Simon, T Hahn, L A Ford, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Acute Myelogenous LeukemiaF R Appelbaum, M R Baer, M H Carabasi, et al.
Bone Marrow Transplantation|August 6, 2003
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patientsT Hahn, C Rondeau, A Shaukat, et al.
Blood|September 15, 1996
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemiaJ Jurlander, M A Caligiuri, T Ruutu, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|July 3, 2003
Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftmentT Hahn, U Bunworasate, M C George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administeredJ C Byrd, R K Dodge, A Carroll, et al.
Leukemia|February 16, 2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720M R Baer, S L George, B L Sanford, et al.
Bone Marrow Transplantation|January 25, 2005
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's diseaseT Hahn, M Benekli, C Wong, et al.
Blood|July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabineR M Stone, D T Berg, S L George, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factorsA Alidina, D Lawrence, L A Ford, et al.
Bone Marrow Transplantation|April 25, 2001
Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparinM Simon, T Hahn, L A Ford, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Acute Myelogenous LeukemiaF R Appelbaum, M R Baer, M H Carabasi, et al.
Bone Marrow Transplantation|August 6, 2003
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patientsT Hahn, C Rondeau, A Shaukat, et al.
Blood|September 15, 1996
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemiaJ Jurlander, M A Caligiuri, T Ruutu, et al.
Pageof 10